[Skip to Content]
[Skip to Content Landing]

August 2019 - April 2016

Decade

Year

Issue

August 2017, Vol 2, No. 8, Pages 827-930

In This Issue of JAMA Cardiology

Highlights

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):827. doi:10.1001/jamacardio.2016.3659
Original Investigation

Health Status Benefits of Transcatheter vs Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER 2 Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):837-845. doi:10.1001/jamacardio.2017.2039

This substudy of a randomized trial compares short- and long-term health status outcomes in patients with aortic stenosis treated with either transcatheter or surgical aortic valve replacement.

Trends and Outcomes of Off-label Use of Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry

Abstract Full Text
free access has audio
JAMA Cardiol. 2017;2(8):846-854. doi:10.1001/jamacardio.2017.1685

This registry-based study uses the Transcatheter Valve Therapy Registry to evaluate patterns and adverse outcomes of off-label use of transcatheter aortic valve replacement in US clinical practice.

Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):855-862. doi:10.1001/jamacardio.2017.1978

This pooled-analysis investigates the long-term safety and efficacy of new-generation drug-eluting stents vs early-generation drug-eluting stents in women with acute myocardial infarction.

Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation: A Population-Based Family Cohort Study

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):863-870. doi:10.1001/jamacardio.2017.1855

This nationwide population-based study measures genetic and environmental factors in the familial aggregation of atrial fibrillation and estimates the association of a family history of atrial fibrillation with major adverse cardiovascular events.

Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):872-881. doi:10.1001/jamacardio.2017.1883

This observational cohort study examines the differences between treating patients with atrial fibrillation with 1 stroke risk factor with nonvitamin K antagonist oral anticoagulants vs warfarin.

Association of Body Mass Index With Cardiometabolic Disease in the UK Biobank: A Mendelian Randomization Study

Abstract Full Text
free access has active quiz
JAMA Cardiol. 2017;2(8):882-889. doi:10.1001/jamacardio.2016.5804

This population-based cohort study uses UK Biobank data to examine the association between body mass index and cardiometabolic outcomes in individuals with phenotypic information available in a databank.

Brief Report

Adherence to High-Intensity Statins Following a Myocardial Infarction Hospitalization Among Medicare Beneficiaries

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):890-895. doi:10.1001/jamacardio.2017.0911

This retrospective cohort study estimates the proportion of patients filling high-intensity statin prescriptions following myocardial infarction who continue taking this medication with high adherence and identifies factors associated with remaining on a high-intensity statin with high adherence after myocardial infarction.

Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):896-901. doi:10.1001/jamacardio.2017.1239

This study uses samples from the RELAX clinical trial to determine the effect of sildenafil treatment among individuals with heart failure with preserved ejection fraction.

Effect of Resveratrol on Walking Performance in Older People With Peripheral Artery Disease: The RESTORE Randomized Clinical Trial

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):902-907. doi:10.1001/jamacardio.2017.0538

This randomized clinical trial reports the effect of a daily dose of resveratrol vs placebo on the walking ability and endurance of older people with peripheral artery disease.

National Trends in Use and Outcomes of Pulmonary Artery Catheters Among Medicare Beneficiaries, 1999-2013

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):908-913. doi:10.1001/jamacardio.2017.1670

This cohort study of Medicare beneficiaries examines national trends in pulmonary artery catheter use overall as well as across sociodemographic groups and key clinical conditions, including acute myocardial infarction, heart failure, and respiratory failure.

From the Heart

Outside the Door

Abstract Full Text
JAMA Cardiol. 2017;2(8):829. doi:10.1001/jamacardio.2017.1362
Editorial

Evaluating Evolving Technologies in a Time of Rapid Change: The Case of Transcatheter Aortic Valve Replacement

Abstract Full Text
has audio
JAMA Cardiol. 2017;2(8):830-831. doi:10.1001/jamacardio.2017.1733

Off-label Use of High-Risk Cardiovascular Devices: Widening the Lens

Abstract Full Text
JAMA Cardiol. 2017;2(8):832-834. doi:10.1001/jamacardio.2017.1732

Introducing Emerging Science for the Clinician

Abstract Full Text
JAMA Cardiol. 2017;2(8):835-836. doi:10.1001/jamacardio.2017.1718
Review

Emerging Science for the Clinician

The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review

Abstract Full Text
JAMA Cardiol. 2017;2(8):914-919. doi:10.1001/jamacardio.2017.1713

This review discusses the use of CRISPR-Cas9 in the prevention and treatment of cardiovascular diseases.

JAMA Cardiology Clinical Challenge

Wide Complex Tachycardia in an Elderly Woman

Abstract Full Text
has active quiz
JAMA Cardiol. 2017;2(8):923-924. doi:10.1001/jamacardio.2017.1912

A woman in her 70s with history of hypertension presented to the emergency department experiencing chest pain and dyspnea. What would you do next?

JAMA Cardiology Clinical Guidelines Synopsis

Assessment and Treatment of Syncope

Abstract Full Text
JAMA Cardiol. 2017;2(8):920-921. doi:10.1001/jamacardio.2017.1784

This article presents recommendations for assessing and treating patients with syncope.

Comment & Response

Outcomes Associated With Subcutaneous Implantable Cardioverter Defibrillators—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(8):925-926. doi:10.1001/jamacardio.2017.0304

Outcomes Associated With Subcutaneous Implantable Cardioverter Defibrillators

Abstract Full Text
JAMA Cardiol. 2017;2(8):925. doi:10.1001/jamacardio.2017.0396

Performing Percutaneous Coronary Intervention Without On-Site Cardiac Surgery Is Not a License for Percutaneous Coronary Intervention Instead of Coronary Artery Bypass Grafting—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(8):926-927. doi:10.1001/jamacardio.2017.0532

Performing Percutaneous Coronary Intervention Without On-site Cardiac Surgery Is Not a License for Percutaneous Coronary Intervention Instead of Coronary Artery Bypass Grafting

Abstract Full Text
JAMA Cardiol. 2017;2(8):926. doi:10.1001/jamacardio.2017.0554

Intensity of Statin Treatment and Mortality

Abstract Full Text
JAMA Cardiol. 2017;2(8):927-928. doi:10.1001/jamacardio.2017.0535

Intensity of Statin Treatment and Mortality

Abstract Full Text
JAMA Cardiol. 2017;2(8):928. doi:10.1001/jamacardio.2017.0546

Intensity of Statin Treatment and Mortality—Reply

Abstract Full Text
JAMA Cardiol. 2017;2(8):928-929. doi:10.1001/jamacardio.2017.0549

Difficulties in Testing the Instrument Strength Independent of Direct Effect Assumption in Mendelian Randomization

Abstract Full Text
JAMA Cardiol. 2017;2(8):929-930. doi:10.1001/jamacardio.2017.1572
Editor's Note

Risk and Consequences of Atrial Fibrillation: It’s in the Jeans, Not the Genes

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):871. doi:10.1001/jamacardio.2017.1856

Harnessing Genomic Biobanks to Understand Obesity in Cardiometabolic Disease: Prospects and Pitfalls

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):889. doi:10.1001/jamacardio.2016.5805
JAMA Cardiology Masthead

JAMA Cardiology

Abstract Full Text
free access
JAMA Cardiol. 2017;2(8):828. doi:10.1001/jamacardio.2016.3660
×